Published in Vaccine Weekly, November 9th, 1998
Virologist John Gebhard, Pharmadigm Inc., reported on "DNA Vaccination and Immunological Protection of Aged Mice." In the experiment he described, the model assessed protection from genital herpes after infection with herpes simplex virus type 2 (HSV-2). The protective antigen encoded in the myogenic DNA vaccine is gD2, an important...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.